期刊文献+

SCID小鼠单次唑来磷酸头皮下注射抑制人假体周围骨溶解 被引量:1

Inhibitory effect of zoledronic acid on osteolysis induced by human periprosthetic tissue:an animal study
原文传递
导出
摘要 [目的]评价唑来磷酸在新型动物模型中对人关节假体周围界膜组织诱导的骨溶解的抑制效应。[方法]将髋关节翻修病人体内获得的界膜组织移植到SCIDbeige小鼠颅骨上。术后2d将唑来磷酸直接注射至小鼠头皮下,并在术后2、4周处死动物取出带移植组织的颅骨进一步检测。[结果]移植组织在动物体内存活至少4周,HE染色可见界膜组织引起大量的骨胶原纤维碎裂溶解。界膜组织中TNF-α、IL-6、RANKL和CPK的基因表达和蛋白水平均显著高于对照。单次局部注射唑来磷酸显著降低RANKL和CPK的表达但未影响TNF-α和IL-6的水平。[结论]单次局部注射唑来磷酸可有效抑制人界膜组织诱导的骨溶解,且效应持续。该新型动物模型模拟临床程度高,可作为评价假体周围骨溶解药物抑制效应的平台。 [Objective]To investigate the inhibitory effect of zoledronic acid(ZA) on osteolysis induced by human periprosthetic tissue in a novel animal model.[Method]Human periprosthetic tissue that was harvested from a patient receiving total hip revision was grafted on the calvaria bone of SCID beige mice. ZA was injected directly beneath the scalp of mice once,2 days post surgery. The mice were sacrificed 2 or 4 weeks after transplantation and the calvaria with grafted human tissue was collected for further detection.[Result]The grafted tissues were found survive for at least 4 weeks in the animals. Bone collagen collapse of the calvaria caused by periprosthetic tissue was demonstrated by HE staining. Significantly higher level of TNF-α,IL-6,RANKL and CPK both in gene expression and protein release were detected in PT grafted group,as compared with the control. Once administration of ZA remarkably reduced the expression of RANKL and CPK in both gene and protein level without affecting TNF-α and IL-6.[Conclusion]Once and local injection of ZA effectively inhibits the osteolysis induced by human periprosthetic tissue with a long lasting effect. The novel animal model could serve for evaluating the pharmaceutical effect on periprosthetic osteolysis.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2010年第10期853-858,共6页 Orthopedic Journal of China
关键词 二磷酸盐 动物模型 无菌性松动 RANKL 界膜组织 bisphosphonate animal model aseptic loosening RANKL periprosthetic tissue
  • 相关文献

参考文献23

  • 1Crotti TN, Smith MD, Findlay DM, et al. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin [ J ]. Biomaterials, 2004, 25:565 - 573.
  • 2Haynes DR, Crotti TN, Potter AE, et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis [ J ]. J Bone Joint Surg( Br ), 2001, 83:902 -911.
  • 3周玮,姬秋和,张南雁,王加林.不同浓度葡萄糖对MG63细胞株护骨素和护骨素配体及其相关因子表达的影响[J].医学研究生学报,2007,20(2):146-149. 被引量:6
  • 4Ren W, Yang SY, Wooley PH. A novel murine model of orthopaedic wear-debris associated osteolysis [ J ]. Scand J Rheumatol, 2004,33:349 - 357.
  • 5Yang SY, Nasser S, Markel DC,et al. Human periprosthetic tissues implanted in severe combined immunodeficient mice respond to gene transfer of a cytokine inhibitor [ J ]. J Bone Joint Surg(Am) , 2005,87 : 1088 - 1097.
  • 6王晓庆.人工关节假体周围骨溶解发病机理的研究[J].中国矫形外科杂志,2002,9(4):383-384. 被引量:7
  • 7Epstein NJ, Bragg WE, Ma T, et al. UHMWPE wear debris upregulates mononuclear cell proinflammatory gene expression in a novel murine model of intramedullary particle disease [ J ]. Acta Orthop, 2005,76:412 - 420.
  • 8von KM, Wedemeyer C, Pingsmann A, et al. The decrease of particle-induced osteolysis after a single dose of bisphosphonate[ J]. 2005,26 : 1803 - 1808.
  • 9Ren W, Wu B, Peng X,et al. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model [J]. J Orthop Res, 2006,24:280 -290.
  • 10Ortiz SG, Ma T, Epstein N J, et al. Validation and quantification of an in vitro model of continuous infusion of submicron-sized particles[ J ]. J Biomed Mater Res B Appl Biomater, 2008,84:328 - 333.

二级参考文献54

  • 1刘好,曹仁贤,文格波,刘江华.高糖诱导胰岛细胞凋亡机制的研究[J].医学研究生学报,2005,18(10):882-885. 被引量:15
  • 2王扬天,王坚,马驰原.核因子-κB与糖尿病的关系[J].医学研究生学报,2007,20(3):310-314. 被引量:15
  • 3Greenfield M, Bechtold J. What other biologic and mechanical factors might contribute to osteolysis? [ J] Am Acad Ortho Surg, 2007,16( 1 ) :56-62.
  • 4Avbersek-Luznik I, Rus I, Marc J, et al. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? [ J] Nephrol Dial Transplant ,2005,20(3) :566-570.
  • 5Vitovski S, Jennifer SP, Sayers J, et al. Investigating the interaction between osteoprotegerin and receptor activator of NF-κB or tumor necrosis factor-related apoptosis-inducing ligand[ J]. Biol Chem,2007,282 ( 43 ) : 31601-31609.
  • 6Yamashita T, Yao ZQ, Li F, et al. NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1 [J]. Biol Chem,2007,282 (25) : 18245- 18253.
  • 7Clohisy JC, Hirayama T, Frazier E, et al. NF-κB signaling blockade abolishes implant particle-induced osteoclastogenesis [J]. Orthop Res, 2004,22( 1 ) :13-20.
  • 8Clohisy JC, Frazier E, Hirayama T, et al. RANKL is an essential cytokine mediator of polymethylmethacrylate particleinducedoste oclastogenesis[ J]. Orthop Res,2003,21 (2) :202-212.
  • 9Yang SY, Chen W, Stashenko P. Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation[ J]. J Cell Science ,2007,120( 1 ) :3362-3371.
  • 10Sobacchi C, Frattini A, Guerrini MM, et al. Osteoclast-poor osteopetrosis due to mutations in the gene encoding RANKL [ J ]. Nat Geuet ,2007,39 ( 3 ) :960-962.

共引文献24

同被引文献31

  • 1李宏斌,朱振安,毛远青,严孟宁,汤亭亭,侯筱魁,戴尅戎.阿仑膦酸钠预防磨损颗粒诱导假体周围骨溶解的作用机制[J].中华实验外科杂志,2006,23(2):154-156. 被引量:19
  • 2Revell PA. The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses [ J ]. J R Soe Interface, 2008, 5(28) :1263-1278.
  • 3Shabtai L, Drexler M, Blummberg N. Biphosphonate in the treatment of avascular necrosis of the femoral head [J]. Harefuah, 2012,151 (4) :242-245.
  • 4Im GI, Qureshi SA, Kenney J, et al. Osteoblast proliferation and maturation by bisphosphonates [ J ]. Biomaterials, 2004, 25 (18) : 4105-4115.
  • 5Mathov I, Plotkin LI, Sgarlata CL, et al. Extracellular signal- regulated kinases and calcium channels are involved in the prolif- erative effect of bisphosphonates on osteoblastic cells in vitro [ J ]. J Bone Miner Res, 2001, 16( 11 ) : 2050-2056.
  • 6von Knoch F, Jaquiery C, Kowalsky M, et al. Effects of bisphos- phonates on proliferation and osteoblast differentiation of human bone marrow stromal cells [ J ]. Biomaterials, 2005,26 ( 34 ) : 6941-6949.
  • 7Kobayashi A, Hirano F, Makino I. The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells[J]. Scand J Rheumatol, 2005,34 (6) : 480-484.
  • 8Bellido T, Plotkin LI. Novel actions of bisphosphonates in bone : preservation of osteoblast and osteocyte viability [ J ]. Bone, 2011, 49( 1 ) :50-55.
  • 9Plotkin LI, Lezcano V, Thostenson J, et al. Connexin 43 is required for the anti-apoptotie effect of bisphosphonates on osteo- eytes and osteoblasts in vivo [ J ]. J Bone Miner Res, 2008, 23 (11) : 1712-1721.
  • 10Russell RG. Bisphosphonates : the first 40 years [ J ]. Bone, 2011, 49(1) : 2-19.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部